Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2026-03-18 Report Publication Anno…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj:n palkitsemisraportti 2025 on julkaistu
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1318 characters) stating that the 'Biohit Oyj palkitsemisraportti 2025' (Remuneration Report 2025) has been published and is available as an attachment or via a link. According to the 'Menu vs Meal' rule, an announcement stating that a report has been published is classified as a Report Publication Announcement (RPA), rather than the report itself.
2026-03-18 Finnish
Biohit Oyj Remuneration Report 2025.pdf
Remuneration Information Classification · 100% confidence The document is a 'Remuneration report 2025' for Biohit Oyj. It details the compensation structure, policies, and specific payments made to the Board of Directors and the CEO, including tables comparing remuneration to financial performance. This content aligns perfectly with the definition of a remuneration report, which is categorized under 'DEF 14A' in the provided schema.
2026-03-18 English
Publication of Biohit Oyj Remuneration Report 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1351 characters) stating that the 'Biohit Oyj Remuneration Report 2025' has been published and is attached to the release. Following the 'Menu vs Meal' rule, since this is an announcement of a report's availability rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2026-03-18 English
Biohit Oyj Tilinp��t�stiedote FI 2025.pdf
Earnings Release Classification · 98% confidence The document is a 'Tilinpäätöstiedote' (Financial Statement Release) for Biohit Oyj for the period 1-12/2025. It contains detailed financial highlights, key performance indicators (KPIs), management commentary from the CEO, and future guidance. This is a comprehensive periodic financial report covering the full fiscal year, which fits the definition of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Given that it covers the full year (1-12/2025) and provides a detailed breakdown of financial performance, it is classified as an Earnings Release (ER) as it serves as the initial announcement of the annual financial results. FY 2025
2026-02-11 Finnish
BIOHIT-KONSERNIN TILINPÄÄTÖSTIEDOTE 2025
Audit Report / Information Classification · 98% confidence The document is a 'Tilinpäätöstiedote' (Financial Statements Release) for Biohit Oyj for the year 2025. It contains detailed financial highlights, income statements, balance sheet data, management commentary from the CEO, and future guidance. This is a comprehensive periodic financial report, which falls under the category of an Earnings Release (ER) as it is the initial announcement of the annual financial results, including key performance indicators and management's outlook. FY 2025
2026-02-11 Finnish
Biohit Oyj Financial Statement Release 2025.pdf
Earnings Release Classification · 98% confidence The document is titled 'BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2025'. It provides comprehensive financial results for the full year 2025, including revenue, EBITDA, operating profit, balance sheet data, and management commentary (CEO's review). It is not a short announcement but a detailed report of financial performance. In many jurisdictions, a 'Financial Statement Release' is the primary annual reporting document equivalent to an Annual Report or a comprehensive year-end financial disclosure. Given the depth of the data provided, it fits the definition of an Annual Report (10-K) or a comprehensive financial report. FY 2025
2026-02-11 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.